KILL Mydecine Innovations Group Upsizes Previously Announced Bought Deal
–(BUSINESS WIRE)–
Miller Thomson LLP requests that their press release NewsItemId: 20210120005543 “Mydecine Innovations Group Upsizes Previously Announced Bought Deal” be killed.
The release was issued by Miller Thomson LLP without prior authorization from Mydecine Innovations Group.
Mydecine Innovations Group Media Contacts
Anne Donohoe / Nick Opich
KCSA Strategic Communications
[email protected] / [email protected]
212-896-1265 / 212-896-1206
On behalf of the Board of Directors:
Joshua Bartch, Chief Executive Officer
[email protected]
Corp Communications:
Charles Lee, Investor Relations
[email protected]
+1 720-277-9879
KEYWORDS: Colorado United States North America Canada
INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health Mental Health
MEDIA:
| Logo |
 |